Supplemental material
Leukemia & Lymphoma
Volume 62, 2021 - Issue 1
Original Articles
A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphoma
Pablo Mozasa Department of Hematology, Hospital Clínic de Barcelona, Barcelona, SpainCorrespondence[email protected]
https://orcid.org/0000-0001-9528-4971View further author information
https://orcid.org/0000-0001-9528-4971View further author information, , Alfredo Rivas-Delgadoa Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spainhttps://orcid.org/0000-0003-0385-3415View further author information
https://orcid.org/0000-0003-0385-3415View further author information, Ferran Nadeub Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spainhttps://orcid.org/0000-0003-2910-9440View further author information
https://orcid.org/0000-0003-2910-9440View further author information, Guillem Clotb Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spainhttps://orcid.org/0000-0003-2588-7413View further author information
https://orcid.org/0000-0003-2588-7413View further author information, Juan Gonzalo Correaa Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spainhttps://orcid.org/0000-0001-6470-8102View further author information
https://orcid.org/0000-0001-6470-8102View further author information, , Alex Batallera Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spainhttps://orcid.org/0000-0002-6085-2745View further author information
https://orcid.org/0000-0002-6085-2745View further author information, Tycho Baumanna Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain;b Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spainhttps://orcid.org/0000-0003-4421-0088View further author information
https://orcid.org/0000-0003-4421-0088View further author information, Eva Ginéa Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain;b Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spainhttps://orcid.org/0000-0002-0532-1204View further author information
https://orcid.org/0000-0002-0532-1204View further author information, Julio Delgadoa Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain;b Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spainhttps://orcid.org/0000-0002-5157-4376View further author information
https://orcid.org/0000-0002-5157-4376View further author information, Neus Villamorb Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;d Hematopathology Unit, Department of Pathology, Hospital Clínic de Barcelona, Barcelona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spainhttps://orcid.org/0000-0001-6538-4111View further author information
https://orcid.org/0000-0001-6538-4111View further author information, Elías Campob Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;d Hematopathology Unit, Department of Pathology, Hospital Clínic de Barcelona, Barcelona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain;e Universitat de Barcelona, Barcelona, Spainhttps://orcid.org/0000-0001-9850-9793View further author information
https://orcid.org/0000-0001-9850-9793View further author information, Patricia Pérez-Galánb Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spainhttps://orcid.org/0000-0003-3895-5024View further author information
https://orcid.org/0000-0003-3895-5024View further author information, Laura Magnanoa Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain;b Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spainhttps://orcid.org/0000-0002-6928-8386View further author information
https://orcid.org/0000-0002-6928-8386View further author information & Armando López-Guillermoa Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain;b Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain;e Universitat de Barcelona, Barcelona, Spainhttps://orcid.org/0000-0002-8588-8381View further author information
https://orcid.org/0000-0002-8588-8381View further author information show all